WallStreetZenWallStreetZen

NASDAQ: CAMT
Camtek Ltd Stock

$80.36-3.15 (-3.77%)
Updated Apr 17, 2024
CAMT Price
$80.36
Fair Value Price
$41.25
Market Cap
$3.61B
52 Week Low
$24.89
52 Week High
$90.54
P/E
45.66x
P/B
7.58x
P/S
9.84x
PEG
2.27x
Dividend Yield
1.66%
Revenue
$315.38M
Earnings
$78.63M
Gross Margin
46.8%
Operating Margin
20.74%
Profit Margin
24.9%
Debt to Equity
0.65
Operating Cash Flow
$79M
Beta
1.34
Next Earnings
May 8, 2024
Ex-Dividend
N/A
Next Dividend
N/A

CAMT Overview

Camtek Ltd., together with its subsidiaries, develops, manufactures, and sells inspection and metrology equipment for the advanced interconnect packaging, memory, complementary metal oxide semiconductor image sensors, micro-electro mechanical systems, radio frequency, and other segments of the semiconductor industry. It provides inspection and metrology systems, including Eagle-i, a system that delivers 2D inspection and metrology capabilities; Eagle-AP, which addresses the advanced packaging market using software and hardware technologies that deliver superior 2D and 3D inspection and metrology capabilities on the same platform; and Golden Eagle, a panel inspection and metrology system to support fanout wafer level packaging applications. The company sells its products in the Asia Pacific, the United States, and Europe. Camtek Ltd. was incorporated in 1987 and is headquartered in Migdal HaEmek, Israel.

Zen Score

Industry Average (38)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CAMT scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CAMT ($80.36) is overvalued by 94.82% relative to our estimate of its Fair Value price of $41.25 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
CAMT ($80.36) is not significantly undervalued (94.82%) relative to our estimate of its Fair Value price of $41.25 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
CAMT ($80.36) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 35 more CAMT due diligence checks available for Premium users.

Be the first to know about important CAMT news, forecast changes, insider trades & much more!

CAMT News

Valuation

CAMT fair value

Fair Value of CAMT stock based on Discounted Cash Flow (DCF)
Price
$80.36
Fair Value
$41.25
Overvalued by
94.82%
CAMT ($80.36) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
CAMT ($80.36) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
CAMT ($80.36) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

CAMT price to earnings (PE)

For valuing profitable companies with steady earnings
Company
45.66x
Industry
38.69x
Market
41.64x
CAMT is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CAMT is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

CAMT price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
7.58x
Industry
11.36x
CAMT is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

CAMT price to earnings growth (PEG)

For valuing profitable companies with growth potential
CAMT is poor value relative... subscribe to Premium to read more.
PEG Value Valuation

CAMT's financial health

Profit margin

Revenue
$88.7M
Net Income
$20.8M
Profit Margin
23.4%
CAMT's Earnings (EBIT) of $65.41M... subscribe to Premium to read more.
Interest Coverage Financials
CAMT's profit margin (24.9%) has... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$787.7M
Liabilities
$311.5M
Debt to equity
0.65
CAMT's short-term assets ($546.79M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CAMT's short-term assets ($546.79M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CAMT's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
CAMT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
N/A
Investing
N/A
Financing
N/A
CAMT's operating cash flow ($79.32M)... subscribe to Premium to read more.
Debt Coverage Financials

CAMT vs Semiconductor Equipment Stocks

TickerMarket Cap1d %P/EP/B
CAMT$3.61B-3.77%45.66x7.58x
IPGP$3.89B-0.55%18.18x1.61x
ACLS$3.32B-2.49%13.53x3.84x
KLIC$2.60B-2.91%50.65x2.24x
NVMI$4.94B-3.34%35.97x6.57x

Camtek Stock FAQ

What is Camtek's quote symbol?

(NASDAQ: CAMT) Camtek trades on the NASDAQ under the ticker symbol CAMT. Camtek stock quotes can also be displayed as NASDAQ: CAMT.

If you're new to stock investing, here's how to buy Camtek stock.

What is the 52 week high and low for Camtek (NASDAQ: CAMT)?

(NASDAQ: CAMT) Camtek's 52-week high was $90.54, and its 52-week low was $24.89. It is currently -11.24% from its 52-week high and 222.86% from its 52-week low.

How much is Camtek stock worth today?

(NASDAQ: CAMT) Camtek currently has 44,901,622 outstanding shares. With Camtek stock trading at $80.36 per share, the total value of Camtek stock (market capitalization) is $3.61B.

Camtek stock was originally listed at a price of $6.00 in Jul 28, 2000. If you had invested in Camtek stock at $6.00, your return over the last 23 years would have been 1,239.33%, for an annualized return of 11.94% (not including any dividends or dividend reinvestments).

How much is Camtek's stock price per share?

(NASDAQ: CAMT) Camtek stock price per share is $80.36 today (as of Apr 17, 2024).

What is Camtek's Market Cap?

(NASDAQ: CAMT) Camtek's market cap is $3.61B, as of Apr 18, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Camtek's market cap is calculated by multiplying CAMT's current stock price of $80.36 by CAMT's total outstanding shares of 44,901,622.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.